Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683676 | PMC |
| http://dx.doi.org/10.4103/IJO.IJO_2951_22 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Retinal Microvasculature in Systemic Sclerosis Patients and the Correlation between Nailfold Capillaroscopic Findings and Optical Coherence Angiography Results.
J Clin Med
March 2024
Department of Ophthalmology, Military Institute of Aviation Medicine, 01-755 Warsaw, Poland.
The comparison of retinal perfusion in the eyes of patients with systemic sclerosis (SSc) and in healthy controls using optical coherence tomography angiography (OCTA). The correlation between nailfold capillaroscopy results and OCTA findings among SSc. The study enrolled 31 patients with systemic sclerosis and 41 healthy controls.
View Article and Find Full Text PDFRationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice.
Ophthalmol Sci
December 2023
F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Purpose: To describe the rationale and design of the VOYAGER (NCT05476926) study, which aims to investigate the safety and effectiveness of faricimab and the Port Delivery System with ranibizumab (PDS) for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) in clinical practice. VOYAGER also aims to understand drivers of clinical practice treatment outcomes by gaining novel insight into the intersection of treatment regimens, decisions, anatomic outcomes, and vision.
Design: Primary data collection, noninterventional, prospective, multinational, multicenter clinical practice study.
Assessing electronic device use behaviours in healthy adults: development and evaluation of a novel tool.
BMC Public Health
January 2024
Sport and Health Sciences, University of Exeter, Exeter, UK.
Background: Chronic exposure of the macula to blue light from electronic devices has been identified as a potential macular health concern. The impacts remain poorly investigated as no validated methods to capture usual device use behaviours exist.
Purpose: The aim of this study was to develop and validate the Electronic Device Use Questionnaire (EDUQ) against multiple 24-h electronic device use diaries in healthy Australian and United Kingdom adults.
Not your usual macula edema!
Indian J Ophthalmol
October 2023
Department of Ophthalmology, Vitreoretinal Services, Rajan Eye Care Hospital, Chennai, Tamil Nadu, India.
Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema.
Am J Ophthalmol Case Rep
March 2023
Department of Ophthalmology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Purpose: To describe a case of unilateral retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab (IVBr) treatments for diabetic macular edema (DME).
Observations: A 68-year-old Japanese woman who had a 3-year history of insulin-dependent diabetes mellitus presented with decreased vision in the right eye (oculus dexter, OD). After two consecutive IVBr (3 mg) treatments for DME, spaced 6 weeks apart, her best corrected visual acuity improved from 20/32 to 20/28 OD, as central macular thickness (CMT) decreased from 368 μm to 253 μm on optical coherence tomography (OCT).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!